glp-1 vs sglt2 diabetes GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog SGLT-2 Inhibitors and GLP-1 Agonists:

Role of extracellular matrix and inflammation in abdominal aortic aneurysm

Do not use the remaining medication

Obesity Pillars , 15, p.100186

Far too many hurdles continue to prevent people living with obesity from accessing obesity treatments that could lead to significant weight loss, said Mike Mason, executive vice president and president, Lilly Diabetes and Obesity

However, the relationship between improved glycemic control and cognitive function is complex, as demonstrated by mixed results in large trials like ACCORD-MIND

Some anti-inflammatory effects appear independent of weight loss, which is why microdosing is being explored for RA patients who aren't significantly overweight but have signs of metabolic inflammation